ID   HeLa S3 penta KO
AC   CVCL_C2VN
DR   Wikidata; Q114311582
RX   DOI=10.1101/2023.09.25.559255;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 29912; CALCOCO2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 6746; NBR1.
CC   Knockout cell: Method=TALEN; HGNC; 17142; OPTN.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 11280; SQSTM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 11575; TAX1BP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 6
//
RX   DOI=10.1101/2023.09.25.559255;
RA   Adriaenssens E., Nguyen T.N., Sawa-Makarska J., Khuu G.,
RA   Schuschnig M., Watts E.M., Shoebridge S., Csalyi K.D., Padman B.S.,
RA   Lazarou M., Martens S.;
RT   "Control of mitophagy initiation and progression by the TBK1 adaptors
RT   NAP1 and SINTBAD.";
RL   bioRxiv 2023:09.25.559255-09.25.559255(2023).
//